Liang Shi Shuhong Gao Li Tong Qiyi Meng Shijie Zhou Daping Yu Yujie Dong Zhe Liu
10.3389/fonc.2023.1120511
Front Oncol
2023 Jun 20;13:1120511.
alk rearrangement alectinib lung adenocarcinoma neoadjuvant therapy pathological complete response
CC BY
https://pubmed.ncbi.nlm.nih.gov/37409244/
Systematic Review
PMC10318538
37409244
Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports
2023